etomoxir has been researched along with oligomycins in 1 studies
| Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (oligomycins) | Trials (oligomycins) | Recent Studies (post-2010) (oligomycins) |
|---|---|---|---|---|---|
| 260 | 8 | 93 | 3,033 | 0 | 265 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bettonville, M; Bousbata, S; Braun, MY; d'Aria, S; Porporato, PE; Sonveaux, P; Weatherly, K; Zhang, J | 1 |
1 other study(ies) available for etomoxir and oligomycins
| Article | Year |
|---|---|
Long-term antigen exposure irreversibly modifies metabolic requirements for T cell function.
Topics: Adenosine Triphosphate; Animals; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; B7-H1 Antigen; Cell Lineage; Diazooxonorleucine; DNA-Binding Proteins; Epoxy Compounds; Gene Expression Profiling; Gene Expression Regulation; Glycolysis; Interferon-gamma; Interleukin Receptor Common gamma Subunit; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Oligomycins; Oxidative Phosphorylation; Programmed Cell Death 1 Receptor; Receptors, Antigen, T-Cell; Signal Transduction; T-Lymphocytes; Transplantation, Homologous | 2018 |